Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
Titel:
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
Auteur:
Rizvi, Naiyer A Mazières, Julien Planchard, David Stinchcombe, Thomas E Dy, Grace K Antonia, Scott J Horn, Leora Lena, Hervé Minenza, Elisa Mennecier, Bertrand Otterson, Gregory A Campos, Luis T Gandara, David R Levy, Benjamin P Nair, Suresh G Zalcman, Gérard Wolf, Jürgen Souquet, Pierre-Jean Baldini, Editta Cappuzzo, Federico Chouaid, Christos Dowlati, Afshin Sanborn, Rachel Lopez-Chavez, Ariel Grohe, Christian Huber, Rudolf M Harbison, Christopher T Baudelet, Christine Lestini, Brian J Ramalingam, Suresh S